- Home
- IKT vs GHG Comparison
IKT vs GHG Comparison
Compare IKT & GHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
GHG
GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share
Current Price
Company Overview
Basic Information| Metric | IKT | GHG |
|---|---|---|
| Founded | 2008 | 2004 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 201.3M | 171.6M |
| IPO Year | 2020 | 2017 |
Fundamental Metrics
Financial Performance| Metric | IKT | GHG |
|---|---|---|
| Price | $2.07 | $1.35 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 1.8M | 27.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.72% |
| EPS Growth | ★ 67.51 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $19.02 |
| Revenue Next Year | N/A | $8.26 |
| P/E Ratio | ★ N/A | $5.76 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.33 | $1.36 |
| 52 Week High | $2.58 | $2.83 |
Technical Indicators
Market Signals| Indicator | IKT | GHG |
|---|---|---|
| Relative Strength Index (RSI) | 67.70 | 31.03 |
| Support Level | $1.45 | N/A |
| Resistance Level | $2.11 | $2.29 |
| Average True Range (ATR) | 0.14 | 0.04 |
| MACD | 0.05 | -0.00 |
| Stochastic Oscillator | 75.36 | 0.00 |
Price Performance
Historical ComparisonAbout IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
About GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share
GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The hotel network of the company comprised approximately 4,059 hotels with nearly 302,497 rooms in China, covering all centrally administrated municipalities and cities throughout all provinces and autonomous regions in China. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The company operates solely in China and generates all its revenue from China itself.